{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T04:08:55Z","timestamp":1767499735314},"reference-count":9,"publisher":"Hindawi Limited","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3689,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2005.00545.x","type":"journal-article","created":{"date-parts":[[2005,8,15]],"date-time":"2005-08-15T16:30:15Z","timestamp":1124123415000},"page":"1097-1100","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of management of Graves' disease in District General Hospital: achievement of consensus guidelines"],"prefix":"10.1155","volume":"59","author":[{"given":"S.","family":"Dasgupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. W.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2005,7,26]]},"reference":[{"key":"10.1111\/j.1742-1241.2005.00545.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-8529(05)70189-4","article-title":"Thyroid autoantibodies","volume":"30","author":"Saravanan","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1111\/j.1742-1241.2005.00545.x-BIB2|cit2","first-page":"374","article-title":"Controversy in thyroid disease","volume":"34","author":"Weetman","year":"2000","journal-title":"J R Coll Physicians Lond"},{"key":"10.1111\/j.1742-1241.2005.00545.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/bmj.313.7056.539","article-title":"Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism","volume":"313","author":"Vanderpump","year":"1996","journal-title":"Br Med J"},{"key":"10.1111\/j.1742-1241.2005.00545.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF03348001","article-title":"Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects","volume":"8","author":"Takasu","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1742-1241.2005.00545.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/thy.2000.10.891","article-title":"Remission of Graves hyperthyroidism predicted by smooth decreases of thyroid stimulating antibody and thyrotropin binding inhibitor immunoglobulin during anti thyroid drug treatment","volume":"10","author":"Takasu","year":"2000","journal-title":"Thyroid"},{"key":"10.1111\/j.1742-1241.2005.00545.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199104043241403","article-title":"Administration of thyroxine in treated Graves' disease. Effects on levels of antibodies to thyroid stimulating hormone receptors and on risk of recurrence of hyperthyroidism","volume":"324","author":"Hashizume","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2005.00545.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy","volume":"338","author":"Bartelena","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2005.00545.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.2000.01020.x","article-title":"Antithyroid drug treatment before radioiodine in patients with Graves' disease: soother or menace?","volume":"53","author":"Perros","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1111\/j.1742-1241.2005.00545.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/thy.1998.8.49","article-title":"Prospective and controlled study of ophthalmopathy after radioiodine therapy for Graves' hyperthyroidism","volume":"8","author":"Manso","year":"1998","journal-title":"Thyroid"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2005.00545.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2005.00545.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:05:48Z","timestamp":1643349948000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2005.00545.x"}},"subtitle":["GRAVES' DISEASE"],"short-title":[],"issued":{"date-parts":[[2005,7,26]]},"references-count":9,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2005.00545.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7,26]]}}}